Видео ютуба по тегу Adcetris

ADCETRIS® ClinCases discussion featuring Dr Andrew Whiteley
ADCETRIS® ClinCases discussion featuring Dr Andrew Whiteley
О препарате Адцетрис
О препарате Адцетрис
Amina talks about support when starting ADCETRIS® treatment
Amina talks about support when starting ADCETRIS® treatment
ADCETRIS® mechanism of action
ADCETRIS® mechanism of action
Фармацевтическая VR программа. Действие препарата Адцетрис компании Takeda Oncology
Фармацевтическая VR программа. Действие препарата Адцетрис компании Takeda Oncology
Should Adcetris be Evaluated as a Combination Therapy?
Should Adcetris be Evaluated as a Combination Therapy?
Dr. Smith Discusses Brentuximab Vedotin in CTCL
Dr. Smith Discusses Brentuximab Vedotin in CTCL
The Impact of Brentuximab Vedotin as PTCL Treatment
The Impact of Brentuximab Vedotin as PTCL Treatment
Brentuximab Vedotin in Hodgkin Lymphoma
Brentuximab Vedotin in Hodgkin Lymphoma
Learn how Brandon chose ADCETRIS® for his treatment
Learn how Brandon chose ADCETRIS® for his treatment
Адцетрис принят. Всё, как по маслу!
Адцетрис принят. Всё, как по маслу!
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma
Facebook Live: Brentuximab vedotin (ADCETRIS®) - Steven Horwitz, MD
Facebook Live: Brentuximab vedotin (ADCETRIS®) - Steven Horwitz, MD
FDA Approves Adcetris / brentuximab vedotin + lenalidomide & rituximab in relapsed or refractory LBC
FDA Approves Adcetris / brentuximab vedotin + lenalidomide & rituximab in relapsed or refractory LBC
Mary Ann embraces data and research in considering ADCETRIS®
Mary Ann embraces data and research in considering ADCETRIS®
Phase II study of brentuximab vedotin + CHP in patients with PTCL with less than 10% CD30 expression
Phase II study of brentuximab vedotin + CHP in patients with PTCL with less than 10% CD30 expression
Justin’s diagnosis story | ADCETRIS®
Justin’s diagnosis story | ADCETRIS®
Post-transplant survival boosted by brentuximab vedotin in lymphoma
Post-transplant survival boosted by brentuximab vedotin in lymphoma
Partnering with my oncologist: Mary Ann’s experience with ADCETRIS®
Partnering with my oncologist: Mary Ann’s experience with ADCETRIS®